Procedures: Evolastin

Evolastin is a revolutionary treatment for treating skin laxity and improving appearance that delivers facelift-like results without the “downtime,” especially in the jowls, cheeks and neck. We are one of the first practices in the U.S. to offer this device to patients outside clinical trials.

Evolastin is the first device that delivers precisely controlled energy directly into the deeper layers of the skin to stimulate natural production of collagen plus elastin and hyaluronic acid – the elements that add structure to skin to give facelift-like results, and is the only non-invasive treatment shown to offer significant improvement in all three. A recent clinical study published in the Archives of Dermatology reported that volume restoration with Evolastin resulted in improvement comparable to one third of the tightening seen after a surgical facelift.

evolastin device and histology Evolastin

In one treatment session, Evolastin delivers radiofrequency energy directly into the deep skin layers of the dermis to improve the quality, texture tone and volume of the skin. Prior to treatment, local anesthetic injections are used for optimize comfort during the Evolastin procedure. Recovery time after Evolastin is minimal with most patients experiencing some minor redness, swelling, or bruising for a few days, which are easily covered with makeup. Patients begin to see results within 6-8 weeks post treatment, with results improving continuously for 6 months of more.

Our assessment: Based on our multi-year experience with the device, Evolastin is a highly specialized treatment that can offer excellent results in the hands of a trained physician and for the appropriate patient candidates, especially as part of a complete skin rejuvenation plan. We are pleased to be one of the few practices that can offer this treatment as an option to our patients.

Evolastin Before and After photos, cheeks:
evolastin cheeks before and after Evolastin

Evolastin Before and After photos, jowls:
evolastin jowls before and after Evolastin